Daniel Billen - May 21, 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Daniel Billen, Ph.D.
Stock symbol
AUPH
Transactions as of
May 21, 2024
Transactions value $
-$30,146
Form type
4
Date filed
5/22/2024, 04:14 PM
Previous filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$30.1K -5.25K -15.73% $5.74 28.1K May 21, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.